{"url_path":"/sec/nvax/proxy/2026-04-27/000162828026027330","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001628280-26-027330-index.html","accession_number":"0001628280-26-027330","cik":"0001000694","ticker":"NVAX","issuer_name":"NOVAVAX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001628280-26-027330-index.html","primary_entity_key":"0001000694","primary_entity_name":"NOVAVAX INC"},"word_count":147,"has_tables":true,"body_markdown":"DEFA14A\n1\nnovavaxincdefa14a2026.htm\nDEFA14A\n\nDocument\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\nSCHEDULE 14A\n\n(Rule 14a-101)\n\nINFORMATION REQUIRED IN\n\nPROXY STATEMENT\n\nSCHEDULE 14A INFORMATION\n\nProxy Statement Pursuant to Section 14(a)\n\nof the Securities Exchange Act of 1934\n\nFiled by the Registrant x\n\nFiled by a Party other than the Registrant o\n\nCheck the appropriate box:\n\no    Preliminary Proxy Statement\n\no    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))\n\no    Definitive Proxy Statement\n\nx    Definitive Additional Materials\n\no    Soliciting Material Pursuant to §240.14a-12\n\nNOVAVAX, INC.\n\n(Name of registrant as specified in its charter)\n\n(Name of person(s) filing proxy statement, if other than the registrant)\n\nPayment of Filing Fee (Check all boxes that apply):\n\nx    No fee required.\n\no    Fee paid previously with preliminary materials.\n\no    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11."}